Detalhe da pesquisa
1.
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
BMC Cancer
; 19(1): 971, 2019 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31638937
2.
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.
BMC Cancer
; 15: 235, 2015 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25881228
3.
Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition.
BMC Bioinformatics
; 15: 168, 2014 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24902483
4.
Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfalls.
Front Genet
; 14: 1188472, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37829280
5.
High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients.
Oncotarget
; 10(7): 717-731, 2019 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30774774
6.
Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission.
Exp Hematol Oncol
; 6: 3, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097046
7.
Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.
PLoS One
; 11(4): e0153069, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27045839
8.
The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines.
Biomark Res
; 4: 12, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307990
9.
High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Exp Hematol
; 44(4): 238-46.e2, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26854484
10.
MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.
Oncotarget
; 6(1): 7-25, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25622103
11.
MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.
Dan Med J
; 62(5)2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26050834
12.
Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma.
Exp Hematol
; 42(11): 927-38, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072621